Hikma Pharmaceuticals PLC (HIK.L) LSE
1,421.00
-1(-0.07%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
1,421.00
-1(-0.07%)
Currency In GBp
Address
1 New Burlington Place
London, W1S 2HR
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 20 7399 2760
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9500
First IPO Date
November 01, 2005
| Name | Title | Pay | Year Born |
| Khalid Walid Hussni Al Nabilsi | Deputy CEO of North America and Europe & Director | 32,360 | 1972 |
| Said Samih Taleb Darwazah | Chief Executive Officer | 1.61M | 1957 |
| Mazen Samih Taleb Darwazeh | Executive Vice Chairman & Deputy CEO of MENA | 1.65M | 1958 |
| Hussein Arkhagha | Chief People Officer | 0 | N/A |
| Bassam Wael Rushdi Kanaan | Executive Vice President of Corporate Development and M&A | 0 | 1965 |
| Guy Featherstone | Associate Director of Investor Relations | 0 | N/A |
| Samuel Park | General Counsel | 0 | N/A |
| Patricia Bousfield | Chief Information Officer | 0 | N/A |
| Susan Ringdal | Executive Vice President of Strategic Planning & Global Affairs | 0 | N/A |
| Julie Hill | Senior Vice President of Corporate Quality Compliance/Health & Safety | 0 | N/A |
| Areb KURDI | VP, Group Financial Controller & Acting CFO | 0 | 1974 |
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.